Introduction HIV‐1 transmitted drug resistance (TDR) prevalence increased during the initial
years of the antiretroviral therapy (ART) global scale‐up. Few studies have examined recent …

Background: There are an increasing number of articles focused on the prevalence and
clinical impact of pretreatment HIV drug resistance (PDR) detected by Sanger sequencing …

Associations between HLA class I alleles and HIV progression in populations exhibiting
Amerindian and Caucasian genetic admixture remain understudied. Using univariable and …

Introduction At low mutation-detection thresholds, next generation sequencing (NGS) for HIV-
1 genotypic resistance testing is susceptible to artifactual detection of mutations arising from …

The efficacy of antiretroviral drugs is limited by the development of drug resistance.
Therefore, it is important to examine HIV drug resistance following the nationwide …

Background Pretreatment drug resistance (PDR) levels to NNRTI approaching 10% have
recently been reported in Mexico. However, subnational differences may exist in PDR …

Background Migration and travel are major drivers of the spread of infectious diseases.
Geographic proximity and a common language facilitate travel and migration in …

In the latest HIV-1 global drug resistance report released by WHO, countries are advised to
strengthen pre-treatment monitoring of drug resistance in AIDS patients. In this study, we …

Introduction A nationally representative HIV drug resistance (HIVDR) survey in Nicaragua
was conducted to estimate the prevalence of pretreatment HIVDR (PDR) among …

Human immunodeficiency virus (HIV) remains a public health threat, with drug resistance
being a major concern in HIV treatment. Next-generation sequencing (NGS) is a powerful …